Equities

ZYUS Life Sciences Corp

ZYUS:CVE

ZYUS Life Sciences Corp

Actions
  • Price (CAD)1.04
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ZYUS Life Sciences Corporation is a Canada-based life sciences company. The Company is focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and exempt market therapeutics. Through clinical research, it is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, the Company delivers cGMP / EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The Company is also focused on commercialization of its exempt market therapeutics, such as cannabinoid oils, soft gel capsules and topical creams, in Canada and those international markets where medical cannabis is legal.

  • Revenue in CAD (TTM)387.00k
  • Net income in CAD-41.25m
  • Incorporated1944
  • Employees2.00
  • Location
    ZYUS Life Sciences Corp204 - 407 Downey RoadSASKATOON S7N 4L8CanadaCAN
  • Phone+1 (306) 242-2357
  • Fax+1 (416) 368-4440
  • Websitehttps://www.zyus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Covalon Technologies Ltd26.24m-2.77m49.88m----2.48--1.90-0.1123-0.11231.060.80211.021.844.53---10.83-18.06-12.67-27.1055.8451.89-10.57-27.064.85--0.0597--46.56-0.09651.79--12.21--
KDA Group Inc186.28k133.66k49.99m--141.793.2257.22268.350.0020.09260.00120.08860.0079--0.0693---0.4146-17.96-0.8534-44.6936.5126.76-52.24-28.00---4.310.1287---22.20-62.03106.88--31.67--
LSL Pharma Group Inc12.17m-4.62m51.84m----3.22--4.26-0.056-0.0560.14660.14890.39292.594.87---14.92---21.69--19.76---37.97--0.4505-0.84650.4938--------------
Helix Biopharma Corp.0.00-5.65m58.83m9.00---------0.0277-0.02770.00-0.00120.00----0.00-318.95-261.49-574.76-------------2,825.00--------4.16---28.36--
Simply Better Brands Corp95.08m-30.01m59.65m--------0.6274-0.4156-0.43051.32-0.08542.7112.6817.69---85.10-63.90-361.23-215.4853.52---31.40-29.460.2536-19.653.20--22.08---96.41------
Satellos Bioscience Inc0.00-21.13m60.91m12.00--1.77-----0.1718-0.17180.000.30590.00----0.00-93.29-107.22-109.86-136.58------------0.00-------40.33--459.46--
Medmira Inc407.78k-2.92m64.65m65.00------158.54-0.0042-0.00420.0006-0.02290.09960.78990.3142---71.41-69.95----61.5466.76-717.02-187.610.1342-2.09-----54.57-5.98-46.08------
Cannara Biotech Inc73.38m6.22m64.81m--10.360.81695.450.88320.06950.06950.81730.88140.53372.087.46--4.52-4.466.23-4.9510.0617.868.48-15.880.3582-2.460.384--59.91--201.26------
ZYUS Life Sciences Corp387.00k-41.25m73.68m2.00--3.67--190.39-0.5751-0.57510.00570.28330.0165--0.7911---175.44-57.88-242.41-71.1946.25-16.16-10,658.40-10,367.370.315-7.990.3295--17.79213.99-72.73------
Theratechnologies Inc107.27m-24.72m80.93m89.00------0.7544-0.8509-0.85093.29-0.73491.031.897.81---23.78-26.32-128.23-55.4374.1065.90-23.04-38.261.03-0.9191.71--2.1312.5849.28---37.83--
Data as of Jun 14 2024. Currency figures normalised to ZYUS Life Sciences Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.